117 related articles for article (PubMed ID: 5571114)
1. Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa.
Wilk S; Mones R
J Neurochem; 1971 Sep; 18(9):1771-3. PubMed ID: 5571114
[No Abstract] [Full Text] [Related]
2. 3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
Gordon EK; Oliver J
Clin Chim Acta; 1971 Nov; 35(1):145-50. PubMed ID: 4256760
[No Abstract] [Full Text] [Related]
3. Cerebrospinal fluid homovanillic acid and iso-homovanillic acid: a gas-liquid chromatographic method.
Dziedzic SW; Gitlow SE
J Neurochem; 1974 Mar; 22(3):333-5. PubMed ID: 4829959
[No Abstract] [Full Text] [Related]
4. The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.
Curzon G; Godwin-Austen RB; Tomlinson EB; Kantamaneni BD
J Neurol Neurosurg Psychiatry; 1970 Feb; 33(1):1-6. PubMed ID: 5418176
[No Abstract] [Full Text] [Related]
5. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Chase TN; Gordon EK; Ng LK
J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
[No Abstract] [Full Text] [Related]
6. L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism.
Weiner W; Harrison W; Klawans H
Life Sci; 1969 Sep; 8(17):971-6. PubMed ID: 5808572
[No Abstract] [Full Text] [Related]
7. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.
Godwin-Austen RB
J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):219-23. PubMed ID: 5571307
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal homovanillic acid and parkinsonism.
Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
[No Abstract] [Full Text] [Related]
9. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
Johansson B; Roos BE
Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
[No Abstract] [Full Text] [Related]
10. Correlations between a fluorimetric and mass fragmentographic method for the determination of 3-methoxy-4-hydroxyphenylacetic acid and two mass fragmentographic methods for the determination of 3-methoxy-4- hydroxyphenylethylene glycol in cerebrospinal fluid.
Muskiet FA; Jeuring HJ; Korf J; Sedvall G; Westerink BH; Teelken AW; Wolthers BG
J Neurochem; 1979 Jan; 32(1):191-4. PubMed ID: 759571
[No Abstract] [Full Text] [Related]
11. Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa).
Sharpless NS; Ericsson AD; McCann DS
Neurology; 1971 May; 21(5):540-9. PubMed ID: 5104098
[No Abstract] [Full Text] [Related]
12. Parkinsonism-dementia of Guam: treatment with L-dopa.
Schnur JA; Chase TN; Brody JA
Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
[No Abstract] [Full Text] [Related]
13. The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography.
Bond PA
Biochem Med; 1972 Feb; 6(1):36-45. PubMed ID: 4260101
[No Abstract] [Full Text] [Related]
14. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
van Woert MH; Bowers MB
Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
[No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
Chase TN
Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
[No Abstract] [Full Text] [Related]
16. Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid.
Wilk S; Davis KL; Thacker SB
Anal Biochem; 1971 Feb; 39(2):498-504. PubMed ID: 4325071
[No Abstract] [Full Text] [Related]
17. Serial determinations of homovanillinic acid in the cerebrospinal fluid of Parkinson patients treated with L-dopa.
Bertler A; Jeppsson PG; Nordgren L; Rosengren E
Acta Neurol Scand; 1971; 47(4):393-402. PubMed ID: 4941731
[No Abstract] [Full Text] [Related]
18. Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease.
Ebinger G; Adriaenssens K
Clin Chim Acta; 1973 Nov; 48(4):427-31. PubMed ID: 4761590
[No Abstract] [Full Text] [Related]
19. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
Voto Bernales J; Cruz GA; Davila E
Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
[No Abstract] [Full Text] [Related]
20. Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid.
Extein I; Korf J; Roth RH; Bowers MB
Brain Res; 1973 May; 54():403-7. PubMed ID: 4709155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
